Posted by Michael Wonder on 24 Jun 2023
Leo Pharma receives positive CHMP opinion for new Adtralza (tralokinumab) injection device
23 June 2023 - CHMP recommends approval of the Adtralza pre-filled pen.
Leo Pharma today announced that the CHMP of the EMA has adopted a positive opinion that recommends the approval of Adtralza (tralokinumab) solution for injection in a new single dose (300 mg) 2 ml pre-filled pen.
